Skip to main content
. Author manuscript; available in PMC: 2022 Jan 8.
Published in final edited form as: Circ Res. 2017 Sep 18;121(11):1279–1290. doi: 10.1161/CIRCRESAHA.117.311827

Figure 5. Effects of hMSCs on serum TNF-α in ICM Patients.

Figure 5.

Cell treatment improved serum TNF-α at 6 months post-TESI by −5.96pg/mL in 20M (p=0.01) and −9.37pg/mL in 100M (p=0.0004), between groups (p=0.96). *Within-group p≤0.05, ***within-group p≤0.0005.